IMMUNE MONITORING WITH UREA-FORMULATED EBV PROTEINS FOR PREDICTION OF EBV REACTIVATION IN RENAL TRANSPLANT PATIENTS

被引：0
|
作者：
Barabas, S. [1 ,2 ]
Zeman, F. [3 ]
Pfister, A. [2 ]
Bendfeldt, H. [1 ]
Starke, A. [1 ]
Jilg, W. [2 ]
Wolf, H. [2 ]
Koller, M. [3 ]
Banas, B. [4 ]
Kraemer, B. K. [5 ]
Deml, L. [1 ,2 ]
机构：
[1] Lophius Biosci GmbH, Regensburg, Germany
[2] Univ Med Ctr, Inst Med Microbiol & Hyg, Regensburg, Germany
[3] Univ Med Ctr, Ctr Clin Studies, Regensburg, Germany
[4] Univ Med Ctr, Dept Internal Med 2, Regensburg, Germany
[5] Univ Heidelberg, Med Fac Mannheim, D-6800 Mannheim, Germany
来源：
TRANSPLANT INTERNATIONAL | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：57 / 57
页数：1
相关论文
共 43 条
  • [21] Use of EBV PCR for the diagnosis and monitoring of post-transplant lymphoproliferative disorder in adult solid organ transplant patients
    Tsai, DE
    Nearey, M
    Hardy, CL
    Tomaszewski, JE
    Kotloff, RM
    Grossman, RA
    Olthoff, KM
    Stadtmauer, EA
    Porter, DL
    Schuster, SJ
    Luger, SM
    Hodinka, RL
    AMERICAN JOURNAL OF TRANSPLANTATION, 2002, 2 (10) : 946 - 954
  • [22] EBV-reactivation, -disease and EBV-induced post-transplant lymphoproliferative disease after haploidentical stem cell transplantation:: a single-centre experience of 57 patients
    Tischer, J
    Rieger, C
    Ledderose, G
    Hill, W
    Weisser, M
    Schmid, C
    Jäger, G
    BONE MARROW TRANSPLANTATION, 2005, 35 : S173 - S173
  • [23] Prospecitve quantitative PCR monitoring of allogeneic stem cell transplant (SCT) patients at high risk for EBV associated PTLD
    Omar, Hamdy
    Hagglund, Hans
    Gustafsson-Jernberg, Asa
    Le Blanc, Katarina
    Mattson, Jonas
    Remberger, Mats
    Ringden, Olle
    Sparrelid, Elda
    Sundin, Mikael
    Winiarski, Jacek H.
    Yun, Zhibing
    Ljungman, Per T.
    BLOOD, 2007, 110 (11) : 872A - 872A
  • [24] Diagnostic Utility of the 18f-FDG PET/CT Scan in Solid Organ Transplant Patients with EBV Reactivation at Risk for Post-Transplant Lymphoproliferative Disorder
    Cherng, Hua-Jay J.
    Scalabrino, Rebecca
    Gould, Patrick
    Sanjurjo, Alexander
    Cuzzo, Brian
    Jain, Saagar
    Ma, Hong Y.
    Ford, Maegan
    Orlando, Evelyn H.
    De Jong, Dorine
    Orjuela, Manuela A.
    Lipsky, Andrew H.
    Tolu, Seda S.
    Pro, Barbara
    Amengual, Jennifer E.
    Capaccione, Kathleen M.
    BLOOD, 2024, 144 : 3077 - 3078
  • [25] Induction of pre-transplant Epstein-Barr virus (EBV) infection by donor blood transfusion in EBV-seronegative recipients may reduce risk of post-transplant lymphoproliferative disease in adolescent renal transplant patients: report of two cases
    Babel, N
    Gabdrakhmanova, L
    Hammer, M
    Rosenberger, C
    Oppert, M
    Volk, HD
    Reinke, P
    TRANSPLANT INFECTIOUS DISEASE, 2005, 7 (3-4) : 133 - 136
  • [26] Oral shedding of HSV-1 and EBV and oral manifestations in paediatric chronic kidney disease patients and renal transplant recipients
    Caliento, Rubens
    de Santana Sarmento, Dmitry Jose
    Pereira Silva, Erika Mont'alverne
    Tozetto-Mendoza, Tania Regina
    Tobouti, Priscila Lie
    Benini, Vanda
    Braz-Silva, Paulo Henrique
    Gallottini, Marina
    ACTA ODONTOLOGICA SCANDINAVICA, 2018, 76 (08) : 539 - 544
  • [27] Role of anti-viral agents in Epstein-Barr Virus (EBV) disease in post renal transplant patients.
    Okafor, Ikechukwu A.
    Connell, Marie O.
    Connell, Jeff
    Awan, Atif
    PEDIATRIC TRANSPLANTATION, 2007, 11 : 87 - 88
  • [28] PREEMPTIVE RITUXIMAB TREATMENT MAY REDUCE THE INCIDENCE OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS (PTLD) IN PATIENTS WITH EBV REACTIVATION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
    Kindwall-Keller, T. L.
    Cooper, B. W.
    Laughlin, M. J.
    Gerson, S. L.
    Barr, P.
    Erinc, S.
    Creger, R. J.
    Lazarus, H. M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 91 - 91
  • [29] Plasma EBV quantification is associated with the efficacy of immune checkpoint blockade and disease monitoring in patients with primary pulmonary lymphoepithelioma-like carcinoma
    Zhong, Yu-Min
    Chen, Ji
    Jiang, Jie
    Zhou, Wen-Bin
    Gao, Ling-Ling
    Zhang, Shui-Lian
    Yan, Wen-Qing
    Chen, Yu
    Zhang, Dong-Kun
    Lu, Dan-Xia
    Lv, Zhi-Yi
    Xie, Zhi
    Huang, Ying
    Guo, Wei-Bang
    Wang, Bin-Chao
    Yang, Jin-Ji
    Yang, Xue-Ning
    Wu, Yi-Long
    Zhang, Xu-Chao
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2024, 13 (06)
  • [30] Immune monitoring with iTAg and Oχιρχ; MHC tetramers:: Prediction of recurrent CMV reactivation in allogeneic stem cell transplant recipients.
    Gratama, JW
    Brooimans, R
    Lowenberg, B
    Sullivan, L
    Gasior, G
    Boyce, C
    Southwick, P
    Cornelissen, J
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2004, 62B (01): : 63 - 63
12345